04.29.2013, 3TV News: Dr. Karmella Haynes, a stem cell expert at Arizona State University said this is just the beginning for stem cell therapy using a person’s own stem cells. “Just recently we’ve seen scientists start to develop stem cell therapies that address different types of diseases, spinal cord therapies, brain tissue diseases, replacing the heart muscle,” Haynes said. “There is even an example of replacing a lost tooth.”
Read more at the 3TV website.
03.18.2013, ASU Research Matters: March is Women’s History Month. The National Women’s History Project declared this year’s theme “Women Inspiring Innovation through Imagination,” celebrating women’s extraordinary contributions to science, technology, engineering and mathematics (STEM) … Karmella Haynes: I am lucky to have several role models who are women and strong leaders in the STEM fields. One I’d like to highlight is Tuajuanda Jordan, a scientist, professor, and dean of the College of Arts and Sciences at Lewis & Clark in Oregon.
Read more at ASU Research Matters.
Dr. Karmella Haynes will present “Synthetic Biology: From Copying Life to Building Life” at the Arizona Science Center on Sunday, March 10, 2013. Visit http://azscience.org/who_are_you/new_frontiers_in_medical_science for details on the event.
Congratulations to Caroline Hom (Fulton Undergraduate Research Initiative fellow) and the 2012 ASU iGEM team members Khateeb Hyder Hussain, Ryan Muller, Nisarg Patel, and Abhinav Markus (FURI) for being invited to give oral presentations at the 2013 Institute for Biological Engineering conference this week!
Preparing synthetic biology for the world
Moe-Behrens GHG, Davis R, Haynes KA (2013) Front. Microbio. 4: 1-10. PMID: 23355834
Synthetic biology aims to develop self-replicating systems that are durable enough to operate reliably in complex environments such as the human gut, polluted soil, and other areas in which disease or toxins need to be remediated. Although helpful, this robustness in “open environments” (outside of the research lab) has raised concerns about lack of control of genetically engineered cells. In this review we discuss early development and advances (from the 1980’s to the present) in built-in, genetically encoded safety switches.